Access cutting-edge gout treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access gout specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gout treatment provided free
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.
Sponsor: Crystalys Therapeutics
Check if you qualify for this gout clinical trial in Birmingham, AL
If you're searching for gout treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gout specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.